Gatenbee, Chandler D. http://orcid.org/0000-0002-9730-5964
Baker, Ann-Marie http://orcid.org/0000-0001-8905-9137
Schenck, Ryan O. http://orcid.org/0000-0002-0294-0106
Strobl, Maximilian http://orcid.org/0000-0003-4484-8823
West, Jeffrey http://orcid.org/0000-0001-9579-4664
Neves, Margarida P.
Hasan, Sara Yakub
Lakatos, Eszter http://orcid.org/0000-0002-7221-6850
Martinez, Pierre
Cross, William C. H.
Jansen, Marnix http://orcid.org/0000-0003-0645-564X
Rodriguez-Justo, Manuel http://orcid.org/0000-0001-5007-1761
Whelan, Christopher J. http://orcid.org/0000-0001-7511-2603
Sottoriva, Andrea http://orcid.org/0000-0001-6709-9533
Leedham, Simon
Robertson-Tessi, Mark http://orcid.org/0000-0003-0143-9587
Graham, Trevor A. http://orcid.org/0000-0001-9582-1597
Anderson, Alexander R. A. http://orcid.org/0000-0002-2536-4383
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (U54CA193489, U54CA193489, U01CA23238, U54CA193489, U01CA232382)
Wellcome Trust (202778/B/16/Z), 206314/Z/17/Z, 105104/Z/14/Z)
Bowel and Cancer Research Charity
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Bowel and Cancer Research Charity Barts Charity
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Moffitt Cancer Center of Excellence for Evolutionary Therapy
Article History
Received: 10 August 2021
Accepted: 24 February 2022
First Online: 4 April 2022
Competing interests
: The authors declare no competing interests.